Access to Medicines: The Role and Impact of US Innovation Policy

The COVID crisis has reminded us of the many ways in which the United States government is involved in developing and distributing live-saving medicine. This symposium explored many of the tools available to help accelerate the pace of innovation and increase availability of medicines, as well as the merits of using those tools.

Co-Hosted with the NYU Journal of Intellectual Property and Entertainment Law.